It is being studied for androgenetic alopecia, telogen effluvium, and other forms of hair thinning, with a focus on increasing hair follicle size and density
Tirzepatide, a first-in-class dual GIP and GLP-1 receptor agonist activating two incretin pathways
2 Metabolic effects of recombinant human growth hormone: isotopic studies in the postabsorptive state and during total parenteral nutrition. National Center for Biotechnology Information
the data from these two large, well-powered clinical trials will provide robust evidence on the cardiovascular and metabolic benefits of tirzepatide, potentially expanding the treatment options for adults with T2DM, obesity, and related cardiovascular complications [7] (Clinical Traials.gov)
Using single-factor analysis of variance, we compared the means of multiple samples, and the t test was used to compare the means of two samples